businesspress24.com - Critical Outcome Technologies Grants Stock Options
 

Critical Outcome Technologies Grants Stock Options

ID: 1272829

(firmenpresse) - LONDON, ONTARIO -- (Marketwired) -- 10/15/13 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that pursuant to an existing consulting agreement, the Board of Directors granted 200,000 stock options (Options) to Dr. Brent Norton who is also a director of the Company, on October 15, 2013.

The Options are exercisable at a price of $0.24 and have a five year expiry term. The Options vest as follows: 50,000 immediately and 50,000 on each of December 1, 2013, March 1, 2014 and June 1, 2014.

About Critical Outcome Technologies Inc. (COTI)

COTI is a leading-edge technology company specializing in accelerating the discovery and development of small molecules - dramatically reducing the time and cost to bring new drugs to market. COTI'S proprietary artificial intelligence system, CHEMSAS®, utilizes a series of predictive computer models to identify compounds with a high probability of being successfully developed from disease specific drug discovery through chemical optimization and preclinical testing. These compounds are targeted for a variety of diseases, particularly those for which current treatments are either lacking or ineffective.

Follow (at)CriticalOutcome on Twitter at

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
Critical Outcome Technologies Inc.
Dr. Wayne Danter
President & CEO
519-858-5157



Heisler Communications
Trevor Heisler
Investor Relations
416-500-8061




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Adherex Announces Updated Guidance for Sodium Thiosulfate (STS) Results
Aoxing Pharmaceutical Company, Inc. Announces Financial Results for 2013 Fiscal Year
Bereitgestellt von Benutzer: Marketwired
Datum: 15.10.2013 - 14:30 Uhr
Sprache: Deutsch
News-ID 1272829
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

LONDON, ONTARIO


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 101 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Critical Outcome Technologies Grants Stock Options
"
steht unter der journalistisch-redaktionellen Verantwortung von

Critical Outcome Technologies Inc. (COTI) (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Critical Outcome Technologies Inc. (COTI)



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 98


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.